Michael Trauner
0000-0002-1275-6425
Publication & Citation Trends
Publications
0 total
Impact of pharmacological sGC stimulation with Riociguat in experimental models of liver disease regression
Cited by 0
Semantic Scholar
The Alpha‐1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD
Cited by 1
Semantic Scholar
Response-guided bulevirtide ± pegylated interferon alfa-2a: long-term outcomes observed in the nationwide Austrian hepatitis D cohort study
Cited by 0
Semantic Scholar
Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensation.
Cited by 0
Semantic Scholar
WED-241 Changes in spleen stiffness as assessed via vibration-controlled transient elastography at 100 Hz reflect acute hepatic venous pressure gradient response to i.v. propranolol: a european multicenter study
Cited by 0
Semantic Scholar
Elevated Hepatic Copper Content in Porto‐Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong Track
Cited by 0
Semantic Scholar
TOP-190 Biomarkers of pathophysiological mechanisms identify stage- specific divers of disease progression in ACLD
Cited by 0
Semantic Scholar
Incidence and clinical significance of recompensation after HCV-cure. OA
Cited by 12
Semantic Scholar
Research Topics
Liver Disease Diagnosis and Treatment
(775)
Liver Disease and Transplantation
(496)
Liver Diseases and Immunity
(368)
Drug Transport and Resistance Mechanisms
(297)
Pediatric Hepatobiliary Diseases and Treatments
(203)
Affiliations
Yamagata University
Hiroshima University
Goethe University Frankfurt
University of Modena and Reggio Emilia
Marche Polytechnic University